Anti-Human ARSA DyLight® 550 conjugated Antibody(monoclonal, 4C10)
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| FC |
---|---|
Primary Accession | P15289 |
Host | Mouse |
Isotype | Mouse IgG2a |
Reactivity | Human |
Clonality | Monoclonal |
Format | Liquid |
Description | Anti-Human ARSA DyLight® 550 conjugated Antibody (monoclonal, 4C10) . Tested in Flow Cytometry applications. This antibody reacts with Human. |
Gene ID | 410 |
---|---|
Other Names | Arylsulfatase A, ASA, 3.1.6.8, Cerebroside-sulfatase, Arylsulfatase A component B, Arylsulfatase A component C, ARSA |
Calculated MW | 53588 Da |
Application Details | Flow Cytometry, 1-3 µg/1x10^6 cells |
Subcellular Localization | Lysosome. |
Contents | Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4, 0.02% NaN3. |
Clone Names | Clone: 4C10 |
Immunogen | A synthetic peptide corresponding to a sequence at the C-terminus of human ARSA, different from the related mouse sequence by six amino acids. |
Cross Reactivity | No cross-reactivity with other proteins. |
Storage | At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light. |
Name | ARSA |
---|---|
Function | Hydrolyzes cerebroside sulfate. |
Cellular Location | Endoplasmic reticulum. Lysosome |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Arylsulfatase A (ARSA) is an enzyme that breaks down sulfatides, namely cerebroside 3-sulfate intocerebroside and sulfate. In humans, arylsulfatase A is encoded by the ARSA gene. ARSA is mapped to 22q13.33. The protein encoded by this gene hydrolyzes cerebroside sulfate to cerebroside and sulfate. Defects in this gene lead to metachromatic leucodystrophy (MLD), a progressive demyelination disease which results in a variety of neurological symptoms and ultimately death. Alternatively spliced transcript variants have been described for this gene.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.